Filing Details
- Accession Number:
- 0001209191-16-138836
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-08-26 17:52:09
- Reporting Period:
- 2016-08-22
- Filing Date:
- 2016-08-26
- Accepted Time:
- 2016-08-26 17:52:09
- Original Submission Date:
- 2016-08-24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879407 | Arrowhead Pharmaceuticals Inc. | ARWR | Pharmaceutical Preparations (2834) | 460408024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486672 | Allen Kenneth Myszkowski | 225 S. Lake Avenue Suite 1050 Pasadena CA 91101 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-22 | 13,100 | $2.01 | 128,789 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-22 | 13,100 | $8.00 | 115,689 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-08-23 | 6,900 | $2.01 | 122,589 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-23 | 6,900 | $8.00 | 115,689 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-08-22 | 13,100 | $0.00 | 13,100 | $2.01 |
| Common Stock | Stock Option (right to buy) | Disposition | 2016-08-23 | 6,900 | $0.00 | 6,900 | $2.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 348,900 | 2013-06-01 | 2023-05-06 | No | 4 | M | Direct |
| 342,000 | 2013-06-01 | 2023-05-06 | No | 4 | M | Direct |
Footnotes
- Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- Represents first vesting date. Option vests over four years from date of grant.
Billionaire Hedge Funds
